Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 500 to 2000
    • Primary and study completion dates: Jan 2018 to Jan 2028
    • Study description expanded, about 81 words
    • Publications: 9 to 23
    v4
  2. Primary and study completion dates: Jan 2018
    • Publications: 1 to 9
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This observational study is for individuals with Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations that are reviewed at the Hammersmith Hospital, London.
Trial Details
NCT Number NCT00230685
Lead Sponsor Imperial College London
Collaborators: The Margaret Hayton HHT Fund
Conditions
(from sponsor)		 Telangiectasia, Hereditary Hemorrhagic
Related terms Telangiectasia, Hereditary Hemorrhagic
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov